[email protected]
+918401209201
Login
Register
SRJBL Home
About
About Us
Aim and Scope
Subjects
AI and Peer Review
Manuscript Type
Open Access
Creative Commons License
Research Topics
Indexing and Partners
Impact Factor
Testimonials
Journals
Information
For Author
For Editorial Board
For Policies and Ethics
Articles Processing Charges
Browse
Current Issue
Archive
Advanced Search
Submit Manuscript
Editorial Board
Join Editorial Board
News & Update
Blog
FAQ
Contact Us
Topic for Research in the Field of Microbiology
SRJBL Home
About
Research Topics
Topic for Research in the Field of Microbiology
IT
ISRDO Team
01 Dec, 2022 -
in Microbiology
457
genomic
extinction
infectious
metagenomics
microbial
The development of a highly efficient capsid characterizes HIV epidemics.
Protecting the Earth's Surface Microbiome
Using the Microbial World to Halt Species Extinction
Genomic prediction of infectious diseases: a promising new field
Cellular processes in archaea
The Omicron form of SARS-CoV-2 evolved as a result of immunological selection.
HIV pandemics are characterized by their ability to evade cGAS and TRIM5.
In Apicomplexa, the construction of glideosomes, which control motility and invasion, is regulated by the extrusion of conoids.
Variation of pneumococci inside a host during colonization, transmission and therapy
A Prospective Cohort of Critically Ill Adults: Integrated Host-Microbe Plasma Metagenomics for the Diagnosis of Sepsis
The plant microbiome is regulated by a wide variety of MarR bacteria involved in auxin catabolism.
The enterotoxin tilimycin, which is produced by Klebsiella in mice, promotes the development of mutations and resistance to antibiotics.
SIR2-dependent NAD+ depletion, one of several phage resistance mechanisms, suppresses infection.
When mobile genetic elements threaten a population, short prokaryotic Argonauts deplete the cellular supply of NAD+ as a defense mechanism.
Self-targeting CRISPR type IV interference from Pseudomonas oleovorans characterized.
Concomitant influenza infection Hybrid virus particles consisting of both virus and respiratory syncytial virus are produced.
CRISPR-based oligo recombination gives apicomplexan cysteines the top spot in the search for new drugs.
Phase II randomized clinical study of bamlanivimab shows emergence of SARS-CoV-2 escape mutations